To present an opportunity that may meet our investment criteria, please provide a non-confidential summary for our consideration at info@bracepharma.com.

Our Investment Criteria

Therapy

 

 

Innovative, life changing therapies for diseases with a high degree of unmet medical need and insufficient treatment options

Development Phase

 

 

Clinical stage projects with potential to go to market in 3-5 years

Pre-clinical stage projects with predictive animal models and potential to go to market in 5-7 years

Development Strategy

 

 

High probability of technical and regulatory success with well defined, FDA validated, clinical efficacy endpoints
Orphan Drug Development

 

 

Preference for disease modifying treatments for debilitating orphan diseases  
U.S. Market Potential

 

 

In excess of $200M revenue potential
Specialty Sales Force

 

 

Up to 100 representatives
Management

 

 

Highly experienced management team with an established track record of successful pharmaceutical development